This is the archive of Swiss Biotech Day, up to the 2026 edition. For the current edition, visit swissbiotechday.ch.
Company name
cellvie AG
Company profile

At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism. We are deriving medicines from cells, leveraging one of the cornerstones of evolution: mitochondria.

Date, time and room information

Tuesday, May 5, 12:45 - 13:00, room Singapore

Category
Emerging biotech company
Title of the presentation
Mitochondria therapy: from cells to medicine
Speaker information
Name Position Institution
Martijn Brugman Chief Operations Officer cellvie AG